Therefore, we simultaneously examined the effects of PEAK1 on activation of the serine/threonine kinase (AKT), MAPKs, Rac1 and JAK1/2 signaling pathways in NSCLC cells. The gene discussed is PEAK1; the disease is non-small cell lung carcinoma.